Fosfonet

Fosfonet

SCHEMBL15612

O=C(O)CP(=O)(O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fosfonet SCHEMBL10490966 0.97 MEN1 (0.93) —
Fosfonet SCHEMBL28151124 0.97 — —
Fosfonet SCHEMBL26676053 0.97 MEN1 (0.93) —
Fosfonet SCHEMBL9162319 0.97 — —
Fosfonet SCHEMBL4607410 0.97 MEN1 (0.93) —
Fosfonet SCHEMBL11026013 0.97 — —
Fosfonet SCHEMBL15510455 0.97 MEN1 (0.93) —
Fosfonet SCHEMBL26676054 0.97 — —
Fosfonet SCHEMBL2801407 0.97 — —
Fosfonet SCHEMBL5521510 0.94 MEN1 (0.88) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12819 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 — — EP claimed
US-20260139860-A1 PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS CENTRE FOR DIGESTIVE DISEASES (AU) 2026-05-21 — — US claimed
EP-4094767-B1 NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO UNIV EMORY (US) 2026-05-20 — — EP claimed
US-12630577-B2 Iron complexes with phosphonate-based ligands as RFB anolyte materials BATTELLE MEMORIAL INSTITUTE (US) 2026-05-19 — — US claimed
EP-4735603-A2 GUIDE RNA COMPOSITIONS nChroma Bio, Inc. (US) 2026-05-06 — — EP claimed
WO-2026090528-A2 CIRCULARLY STRUCTURED GUIDE RNAS FOR CRISPR GENOME EDITING UNIVERSITY OF MASSACHUSETTS (US) 2026-04-30 — — WO claimed
EP-4728071-A1 ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE ProQR Therapeutics II B.V. (NL) 2026-04-22 — — EP claimed
US-20260102422-A1 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO UNIV EMORY (US) 2026-04-16 — — US claimed
EP-4720304-A2 IMPROVED MODULAR PRIME EDITING WITH MODIFIED EFFECTORS AND TEMPLATES University of Massachusetts (US) 2026-04-08 — — EP claimed
US-12595280-B2 Phosphoramidates for the treatment of hepatitis B virus EMORY UNIVERSITY (US) 2026-04-07 — — US claimed
US-4183915-A Stable solution for dental remineralization COLGATE-PALMOLIVE COMPANY (US) 1980-01-15 — — US claimed
US-4178306-A Preparation of N-(phosphonoacetyl)-L-aspartic acid PARSONS JACK L 1979-12-11 — — US claimed
US-4177258-A Dentifrice for dental remineralization COLGATE PALMOLIVE COMPANY (US) 1979-12-04 — — US claimed
US-4138432-A Amides of phosphonoacetic acid ABBOTT LABORATORIES (US) 1979-02-06 — — US claimed
US-4118474-A CATIONIC BIS-GUANIDINO AND QUATERNARY AMMONIUM ANTIPLAQUE AGENTS, PHOSPHONOACETIC ACID COLGATE-PALMOLIVE COMPANY (US) 1978-10-03 — — US claimed
US-4092412-A ADMINISTERING A CARBOXYLIC ESTER OF PHOSPHONOACETIC ACID ABBOTT LABORATORIES (US) 1978-05-30 — — US claimed
US-4087522-A Amides of phosphonoacetic acid for treating herpes simplex virus type 1 and 2 infections ABBOTT LABORATORIES (US) 1978-05-02 — — US claimed
US-4052439-A TREATMENT OF HERPES SIMPLEX INFECTIONS ABBOTT LABORATORIES (US) 1977-10-04 — — US claimed
US-4042324-A Process for inhibiting the corrosions and deposition of boiler scale in water-conveying systems HOECHST AKTIENGESELLSCHAFT (DT) 1977-08-16 — — US claimed
US-4016264-A Wart treatment with phosphonoacetic acid or derivatives thereof THE UNIVERSITY OF UTAH (US) 1977-04-05 — — US claimed
Send feedback